









Markets
/
Stocks
/
nasdaq-iva
/

Inventiva SA

IVA

View Detailed Chart

3.220USD

-0.100-3.01%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Inventiva SA

3.220

-0.100-3.01%

Overview Company Financials

Financials

Intraday

30m

Today

-3.01%

5 Days

+1.69%

1 Month

+6.98%

6 Months

+26.77%

Year to Date

+50.47%

1 Year

+41.85%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 8 analysts

STRONG BUY

Current Rating

7.936

Target Price

146.46%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Inventiva SA

IVA

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(7)

Neutral(4)

Buy(2)

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.006

Sell

RSI(14)

48.150

Neutral

STOCH(KDJ)(9,3,3)

51.134

Neutral

ATR(14)

0.292

High Vlolatility

CCI(14)

31.063

Neutral

Williams %R

51.560

Neutral

TRIX(12,20)

-0.059

Sell

StochRSI(14)

61.692

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

3.195

Buy

MA10

3.245

Sell

MA20

3.290

Sell

MA50

3.302

Sell

MA100

3.288

Sell

MA200

2.918

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.

Ticker SymbolIVA

CompanyInventiva SA

CEOMr. Frederic Cren

Websitehttps://inventivapharma.com/